scorecardresearch
Add as a preferred source on Google
Thursday, April 9, 2026
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Syringes, MRI to ventilators, West Asia war squeezing India’s medical supply chain—costs up 10 to 50%

Industry says manufacturers have 2-4 weeks of buffer stocks, but prolonged disruption could push up shortage risks, especially of consumables like IV and syringes.

Govt planning regulatory sandboxes for pharma sector to fast-track approvals & drug development

On the sidelines of the Bio Asia event in Hyderabad, BIRAC MD Jitendra Kumar says biotechnology department is planning the sandboxes to 'reduce regulatory uncertainty'.

Trump eyes Pharma for next round of tariffs as 1st set of levies kicks in. India pushes for trade deal

India’s pharma industry relies heavily on US market, with $8.07 bn worth of exports in FY 2023-2024. Pharmaceuticals are India’s third largest goods exported to US in dollar terms.

Tariff cloud looming, US study links Indian generic drugs with 54% higher severe adverse events

Researchers associated with The Ohio State University found that number of severe adverse events linked to generic drugs made in India was 54% higher than for those made in the US.

SubscriberWrites: Pharma industry – Yearning for reforms

Despite the critical importance of the Pharma Industry, no attempts were made to resolve the issues & transform the industry.

Drug regulator tightens sampling norms to test quality of medicines & cosmetics reaching market

CDSCO last week notified streamlined guidelines on sampling, conceded that at present sampled drugs are mostly from big brands and urban areas. 

‘Can hamper entry of new drugs’ — groups raise alarm over IP proposals part of India-EFTA talks

India & EFTA (Iceland, Liechtenstein, Norway and Switzerland) are negotiating Trade and Economic Partnership Agreement (TEPA) that is likely to be finalized within next few weeks.

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.

Reporting faulty manufacture to annual audits: How govt wants drugmakers to improve quality

Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.

Slammed by industry, drugs bill set to get delayed as govt plans fresh panel for review

The Drugs, Medical Devices and Cosmetics Bill, 2023, is being planned as a substitute for the existing drug law, which was passed during the pre-Independence period.

On Camera

A stronger Iran has emerged from the rubble. US learned the lesson 40 days late

The US and Israel’s assassinations of Iranian leadership ended up bestowing martyrdom on those killed. Shias saw the deaths as a continuity of martyrdom from the Battle of Karbala.

Data centre gold rush risks blackouts, central electricity body warns states against tripping grids

India’s fast-growing data centre sector may strain state electricity networks; Central Electricity Authority has urged Maharashtra, Andhra Pradesh, Telangana and Tamil Nadu to boost capacity.

Theaterisation proposal to be shared with defence ministry in a week or so—CDS Gen Anil Chauhan

Theaterisation, which aims to divide the forces into three theatres with specific areas of responsibility, will become the single most far-reaching reform that the Indian military has witnessed since independence.

China insulated itself against energy shocks. India is ‘all talk, no walk’

China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.